HIGH-NORMAL ARTERIAL BLOOD PRESSURE IN YOUNG ADULTS AS A PREDICTOR OF ARTERIAL HYPERTENSION: RISK STRATIFICATION AND OPTIMIZATION OF PREVENTION

Authors

Keywords:

high-normal blood pressure; young adults; arterial hypertension; prehypertension; prevention; home blood pressure monitoring; cardiovascular risk.

Abstract

High-normal arterial blood pressure (BP) in young adults is frequently perceived as a benign finding, although longitudinal evidence indicates a substantially increased probability of future hypertension and cumulative cardiovascular exposure.

Objective. To synthesize national and international evidence on the prognostic role of high-normal BP in young people and to propose a practical, risk-stratified prevention model applicable to primary care in Uzbekistan.

Methods. A structured narrative review of 15 core sources published in 2001–2026 was performed using national clinical protocols, Uzbekistan-based publications, WHO materials and major international cohort studies and guidelines.

Results. Uzbekistan data confirm that high-normal BP is already detectable in adolescents and young adults. In the Framingham cohort, 37.3% of participants younger than 65 years with high-normal BP progressed to hypertension within four years. CARDIA data show a graded increase in later cardiovascular event rates across BP categories in young adulthood. The most actionable modifiers are excess body weight, high salt intake, physical inactivity, tobacco exposure, metabolic abnormalities and inadequate BP monitoring.

Conclusion. High-normal BP in young adults should be treated as an early risk state that requires confirmation, cardiovascular risk assessment, structured lifestyle intervention and planned follow-up rather than passive observation.

 

References

1.Ministry of Health of the Republic of Uzbekistan. (2024). National clinical protocol for the management of patients with arterial hypertension. Tashkent, Uzbekistan.

2.Ministry of Health of the Republic of Uzbekistan, & WHO Regional Office for Europe. (2022). Prevalence of risk factors for noncommunicable diseases in the Republic of Uzbekistan, 2019. WHO Regional Office for Europe.

3.Khashimova, Z., Mamasoliev, N., & Kalandarov, D. (2023). Blood pressure levels, prevalence and innovative approaches to prevent arterial hypertension in adolescent and young adult populations. Preventive Medicine and Health, 2(4), 21–29. https://doi.org/10.47689/2181-3663-vol2-iss4-pp21-29

4.Ganikhuzhaeva, Y. D., Matmurodov, R. I., Sadriddinova, M. A., Khasanova, S. I., & Agzamova, Sh. A. (2023). Frequency of arterial hypertension among adolescents living in Tashkent. Nauchnye raboty odarennoy molodezhi i meditsina XXI veka, 56. https://doi.org/10.71337/inlibrary.uz.gifted-youth-medicine.26077

5.Gadayev, A. G., & Gulyamova, Sh. S. (2024). Strengthening the prevention and treatment of hypertension in primary health care. Tashkent Medical Academy Repository, 118–123.

6.Valieva, M. Yu., & Shaxobiddinov, X. M. (2025). Optimization of the management process for patients with arterial hypertension. Journal of IQRO, 15(2), 536–544. https://doi.org/10.71337/inlibrary.uz.iqro.104173

7.Cho‘liyeva, D. E., Bazarova, G. R., & Rizvonqulova, M. V. (2025). Elevated blood pressure in young people: Hypertension. Modern Science and Research, 1147–1153. https://doi.org/10.5281/zenodo.15716188

8.Bobomurodova, A., & Boyqobilov, S. (2025). Anatomical foundations of the causes of arterial hypertension and preventive measures. Universal Science Research Journal, 3(5), 228–230.

9.Mancia, G., Kreutz, R., Brunström, M., et al. (2023). 2023 ESH Guidelines for the management of arterial hypertension. Journal of Hypertension, 41(12), 1874–2071. https://doi.org/10.1097/HJH.0000000000003480

10.McEvoy, J. W., McCarthy, C. P., Bruno, R. M., et al. (2024). 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal, 45(38), 3912–4018. https://doi.org/10.1093/eurheartj/ehae178

11.Whelton, P. K., Carey, R. M., Aronow, W. S., et al. (2018). 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension, 71(6), e13–e115. https://doi.org/10.1161/HYP.0000000000000065

12.Vasan, R. S., Larson, M. G., Leip, E. P., Evans, J. C., O’Donnell, C. J., Kannel, W. B., & Levy, D. (2001). Impact of high-normal blood pressure on the risk of cardiovascular disease. New England Journal of Medicine, 345(18), 1291–1297. https://doi.org/10.1056/NEJMoa003417

13.Vasan, R. S., Larson, M. G., Leip, E. P., Kannel, W. B., & Levy, D. (2001). Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. The Lancet, 358(9294), 1682–1686. https://doi.org/10.1016/S0140-6736(01)06710-1

14.Yano, Y., Reis, J. P., Colangelo, L. A., et al. (2018). Association of blood pressure classification in young adults using the 2017 ACC/AHA blood pressure guideline with cardiovascular events later in life. JAMA, 320(17), 1774–1782. https://doi.org/10.1001/jama.2018.13551

15.Sacks, F. M., Svetkey, L. P., Vollmer, W. M., et al. (2001). Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. New England Journal of Medicine, 344(1), 3–10. https://doi.org/10.1056/NEJM200101043440101

Published

2026-09-22